ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,017Medicare Part D Prescriptions Filled, Including Refills

Rank: 375 out of 2888

$624K Total Retail Price of All Prescriptions

Rank: 583 out of 2888

716 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 716 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 561 406 1 5
LISINOPRIL 507 343 2 3
SIMVASTATIN 458 314 3 2
HYDROCODONE-ACETAMINOPHEN 426 199 S3 4 4
METOPROLOL TARTRATE 402 298 5 10
FUROSEMIDE 326 243 6 6
METFORMIN HCL 322 186 7 8
NEXIUM 275 142 8 19
LEVOTHYROXINE SODIUM 249 168 9 1
OMEPRAZOLE 244 146 10 7
GABAPENTIN 197 107 11 13
HYDROCHLOROTHIAZIDE 177 92 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 104 13 28
POTASSIUM CHLORIDE 167 130 14 14
LOSARTAN POTASSIUM 162 93 15 18
LOVASTATIN 161 118 16 41
GLIPIZIDE 143 106 17 50
CARVEDILOL 135 77 18 21
TRAZODONE HCL 134 70 19 43
TRAMADOL HCL 134 75 19 16
METOPROLOL SUCCINATE 129 100 21 11
CLONIDINE HCL 127 57 22 39
CITALOPRAM HBR 108 69 23 24
MIRTAZAPINE 103 82 24 54
WARFARIN SODIUM 99 86 25 22
CYMBALTA 95 43 26 44
SERTRALINE HCL 90 51 27 27
ATENOLOL 89 67 28 25
CRESTOR 88 50 29 20
CLOPIDOGREL 87 55 30 30
NIFEDIPINE ER 84 70 31 76
LANTUS 84 44 31 45
IBUPROFEN 84 32 31 87
TAMSULOSIN HCL 82 58 34 29
ALENDRONATE SODIUM 81 68 35 23
ZOLPIDEM TARTRATE 78 34 36 17
FLUTICASONE PROPIONATE 77 48 37 32
PRAVASTATIN SODIUM 75 64 38 12
ALLOPURINOL 74 55 39 37
MELOXICAM 72 67 40 31
BACLOFEN 71 13 41 121
AZITHROMYCIN 70 47 42 38
HUMULIN 70-30 70 39 42 230
GLYBURIDE 68 43 R 44 58
PLAVIX 68 48 44 40
DIOVAN HCT 68 52 44 61
DONEPEZIL HCL 67 66 47 26
PREDNISONE 66 34 48 42
HYDRALAZINE HCL 66 36 48 59
PROAIR HFA 65 26 50 71
AMITRIPTYLINE HCL 64 38 R 51 74
RISPERIDONE 61 27 52 72
GLIMEPIRIDE 60 40 53 36
RANITIDINE HCL 60 32 53 56
NOVOLIN R 57 32 55 109
GLIPIZIDE ER 53 27 56 107
ATORVASTATIN CALCIUM 53 35 56 9
QUETIAPINE FUMARATE 50 38 58 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.